NYLTHRQ
NYLTHRQ is a peptide. NYLTHRQ specifically blocks the interaction between sVEGFR1-i13 and β1 integrin, and inhibits the activation of VEGFR1 and VEGFR2. NYLTHRQ inhibits cancer cell proliferation. NYLTHRQ can be used in the research of tumors such as lung squamous cell carcinoma.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 1004284-41-6
- Formel: C40H62N14O12
- Molecular Weight:931.01
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Alle VEGFR Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
|
VEGFR1 |
VEGFR2 |
NYLTHRQ (10 μg/mL; 72 h) specifically blocks the interaction between sVEGFR1-i13 and β1 integrin in MGH7 cells, inhibits VEGFR activation, and reduces cell proliferation activity[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MGH7 squamous cell lung carcinoma (SQLC) cells
-
Concentration:10 μg/mL
-
Incubation Time:72 h
-
Result:Prevented the activation of VEGFR1 (Tyr1213) and VEGFR2 (Tyr1214) proteins.
Blocked the increased cell proliferation induced by sVEGFR1-i13-containing conditioned supernatants.
Chemical Information
-
CAS. Nr. 1004284-41-6
-
Molecular Weight 931.01
-
Formel C40H62N14O12
-
Sequence
Asn-Tyr-Leu-Thr-His-Arg-Gln
-
Sequence Shortening
NYLTHRQ
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Reinheit & Dokumentation
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)